Longboard Pharmaceuticals Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Longboard Pharmaceuticals

Access the complete profile.

Longboard Pharmaceuticals Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Address	4275 Executive Square, Suite 950 La Jolla, CA 92037

Note: Revenues for privately held companies are statistical evaluations.


Longboard Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Longboard Pharmaceuticals's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Longboard Pharmaceuticals is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Longboard Pharmaceuticals Annual Revenue and Growth Rate

Longboard Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Longboard Pharmaceuticals's revenues are gauged from an analysis of company filings.

Longboard Pharmaceuticals's Income Statement (based on Industry Averages)

Longboard Pharmaceuticals P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Longboard Pharmaceuticals is developing and marketing. Longboard Pharmaceuticals doesn't have any recent trademark applications, indicating Longboard Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
LONGBOARD Pharmaceutical preparations and pharmaceutical compounds for the treatment of disorders of the central nervous system	10/02/2020
LONGBOARD PHARMACEUTICALS Pharmaceutical preparations and pharmaceutical compounds for the treatment of disorders of the central nervous system	10/02/2020

See all trademarks and details in the Full Report.

Market Share of Longboard Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Longboard Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Longboard Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
NATIONAL RESILIENCE	La Jolla, CA	100
SYNTRON BIORESEARCH	Carlsbad, CA	11
NATURAL ALTERNATIVES INTERNATIONAL	Carlsbad, CA	7
GREENWICH BIOSCIENCES	Carlsbad, CA	4
CARLSBAD TECHNOLOGY	Carlsbad, CA	2
LONGBOARD PHARMACEUTICALS	La Jolla, CA	1

Future Competition: Longboard Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Longboard Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)